Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Catenae Innovation (CTEA) by Tom Winnifrith in Hot Stock Rockets
- Avoid Best of the Best (BOTB) by Steve Moore in ShareProphets
- Risky Buy British American Tobacco (BATS) by Harvey Jones in The Motley Fool
- Risky Buy Dixons Carphone (DC.) by Harvey Jones in The Motley Fool
- Buy BT Group (BT.A) by Paul Summers in The Motley Fool
- Buy Saga (SAGA) by Paul Summers in The Motley Fool
- Buy Animalcare Group (ANCR) by Royston Wild in The Motley Fool
- Buy GlaxoSmithKline (GSK) by Royston Wild in The Motley Fool
- Buy Brown (N.) Group (BWNG) by Rupert Hargreaves in The Motley Fool
- Buy Regional REIT Limited (RGL) by Rupert Hargreaves in The Motley Fool
- Buy Saga (SAGA) by Numis
- Buy Shanta Gold Ltd. (SHG) by Numis
- Hold Berkeley Group Holdings (The) (BKG) by Numis
- Buy Electrocomponents (ECM) by Numis
- Sell CAP-XX Limited (CPX) by Steve Moore in ShareProphets
- Sell IDOX (IDOX) by Tom Winnifrith in ShareProphets
- Buy Imperial Brands (IMB) by Kevin Godbold in The Motley Fool
- Hold Shire Plc (SHP) by Shore Capital
- Buy Saga (SAGA) by Rupert Hargreaves in The Motley Fool
- Buy Hastings Group Holdings (HSTG) by Rupert Hargreaves in The Motley Fool
AstraZeneca (AZN)
Pharma and Biotech Sector
-
Latest quote
5,255.00p (mid)
-
Current Change (%)
-2.19%
-
Price
Bid: 5,260.00p
Offer: 5,262.00p
-
Today
High: 5,440.00p
Low: 5,245.40p
-
This year
High: 5,508.00p
Low: 4,325.00p
-
Information
Volume: 1,525,477
Market Cap: £66616.92M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| Update: lanabecestat Phase III Alzheimer's trials | 07:00 - June 12, 2018 |
| EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC | 17:30 - June 8, 2018 |
| Director Declaration | 07:00 - June 8, 2018 |
| Total Voting Rights | 15:00 - June 1, 2018 |
| Block listing Interim Review | 15:00 - June 1, 2018 |
| Director Declaration | 11:00 - June 1, 2018 |
| Update on TERRANOVA PIII trial for Fasenra in COPD | 07:00 - May 30, 2018 |
| AZ's Imfinzi: significant OS in Stage III nsclc | 07:00 - May 25, 2018 |
| US FDA approves Lokelma for adult hyperkalaemia | 07:00 - May 21, 2018 |
| AZ regulatory submission in Japan for Forxiga | 07:00 - May 21, 2018 |
| Result of AGM | 17:30 - May 18, 2018 |
| AZN: Q1 2018 Results | 07:00 - May 18, 2018 |
| AstraZeneca update on Fasenra PIII trial in COPD | 07:00 - May 11, 2018 |
| EMA approves Lynparza: maintenance ovarian cancer | 11:00 - May 8, 2018 |
| AZ and Luye Pharma enter agreement for Seroquel | 07:00 - May 8, 2018 |
NOTE: This is based on 177 open tips for this company
